The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Alumis Inc. Common Stock 022307102   7,819,985 1,959,896 SH   SOLE   1,959,896 0 0
Arcellx, Inc. Common Stock 03940C100   192,658,323 2,346,630 SH   SOLE   2,346,630 0 0
ARS Pharmaceuticals, Inc. Common Stock 82835W108   40,329,675 4,012,903 SH   SOLE   4,012,903 0 0
CRISPR Therapeutics AG Common Shares H17182108   132,132,230 2,038,763 SH   SOLE   2,038,763 0 0
Design Therapeutics, Inc. Common Stock 25056L103   49,144,364 6,526,476 SH   SOLE   6,526,476 0 0
enGene Holdings Inc. Common Shares 29286M105   5,107,133 747,750 SH   SOLE   747,750 0 0
Mineralys Therapeutics Inc. Common Stock 603170101   80,160,339 2,113,933 SH   SOLE   2,113,933 0 0
Nkarta, Inc. Common Stock 65487U108   6,899,999 3,333,333 SH   SOLE   3,333,333 0 0
Oculis Holding AG Ordinary Shares H5870P102   5,669,550 322,500 SH   SOLE   322,500 0 0
ORIC Pharmaceuticals, Inc. Common Stock 68622P109   54,179,148 4,514,929 SH   SOLE   4,514,929 0 0
Oruka Therapeutics, Inc Common Stock 687604108   8,275,246 430,330 SH   SOLE   430,330 0 0
Zenas BioPharma, Inc Common Stock 98937L105   109,036,166 4,911,539 SH   SOLE   4,911,539 0 0